Voice disorders in asthma;Stimmstörungen bei asthma bronchiale

Laryngo- Rhino- Otologie

Volumn 89, Issue 8, 2010, Pages 460-464

  Hackenberg, S ^a   Hacki, T ^b   Hagen, R ^a   Kleinsasser, Norbert H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Asthma; Dysphonia; Inhaled corticosteroid therapy; Laryngopharyngeal reflux; Voice disorders

Indexed keywords

CORTICOSTEROID;

ASTHMA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORTICOSTEROID THERAPY; DYSPHONIA; HUMAN; LARYNGOPHARYNGEAL REFLUX; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; DYSPHONIA; HUMANS; LARYNGOSCOPY; LARYNX; MUCUS; PULMONARY VENTILATION; REGURGITATION, GASTRIC; RISK FACTORS; VOCAL CORDS; VOICE DISORDERS;

EID: 77955863070     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0030-1249694     Document Type: Review

References (40)

1. Abbas AK, Lichtmann AH, Pober JS. Cellular and molecular immunology. 4th edition. Saunders text and review series 2000
2. Bachert C, Kardorff B. Allergische Erkrankungen in der Praxis, 2. Auflage Bremen Uni-Med Verlag 2001
3. Ring J. Angewandte Allergologie. München Urban und Vogel Verlag 2004
4. Masoli M, Fabian D, Holt S, Beasley R. Global initiative for Asthma (GINA) Program: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 59 469-478
5. Berdel B, Buhl R, Criée CP, Kardos P. Deutsche Atemwegsliga e. V., Deutsche Gesellschaft für Pneumologie. Leitlinien zur Diagnostik und Therapie von Asthma. Kurzfassung Stuttgart Georg Thieme Verlag 2005
6. Bachert C. Asthma and rhinitis: management implications. Eur Respir J 1997 7 294-295
7. Reinhardt D. Asthma bronchiale im Kindesalter Berlin Springer Verlag 1996
8. Pfaar O, Kardos P, Spielhaupter M, Hörmann K, Klimek L. Asthma bronchiale Was sollte der HNO-Arzt über die Erkrankung wissen? Ein Überblick über die aktuellen Leitlinien. Laryngorhinootologie 2006 85 834-844
9. Berdel B, Buhl R, Dierkesmann R, Niebling W, Schultz K, Ukena D, Worth H. Nationale Versorgungsleitlinie Asthma. Kurzfassung Online http://www.uni- duesseldorf.de/awmf/II/
10. Stanton AE, Sellars C, Mackenzie K, McConnachie A, Bucknall CE. Perceived vocal morbidity in a problem asthma clinic. J Laryngol Otol 2009 123 96-102
11. Dogan M, Eryuksel E, Kocak I, Celikel T, Sehitoglu MA. Subjective and objective evaluation of voice quality in patients with asthma. J Voice 2007 21 224-230 (Pubitemid 46330676)
12. Böhme G. Sprach-, Sprech-, Stimm- und Schluckstörungen. 4. Auflage, Urban und Fischer Verlag 2003
13. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodelling in asthma. Chest 2003 123 417-422
14. Lee L, Chamberlain LG, Loudon RG, Stemple JC. Speech segment duration produced by healthy and asthmatic subjects. J Speech Hear Disord 1988 53 186-193
15. Kleinsasser N. The Kleinsasser's archive of microlaryngoscopy. Tuttlingen Storz Endopress 1999
16. Mirza N, Kasper Schwartz S, Antin-Ozerkis D. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy. Laryngoscope 2004 114 1566-1569
17. Ayache S, Ouaknine M, Dejonkere P, Prindere P, Giovanni A. Experimental study of the effects of surface mucus viscosity on the glottic cycle. J Voice 2004 18 107-115
18. Hosemann W. Sinusitis chronica und obstruktive Atemwegserkrankungen. Laryngo-Rhino-Otol 2000 79 643-644
19. Ostertag P, Kramer MF. Das Sinubronchiale Syndrom. Laryngo-Rhino-Otol 2003 82 459-462
20. Reiter R, Brosch S. Chronische Laryngitis assoziierte Faktoren und subjektive Stimmeinschätzung. Laryngo-Rhino-Otol 2009 88 181-185
21. Krouse JH, Dworkin JP, Carron MA, Stachler RJ. Baseline laryngeal effects amoung individuals with dust mite allergy. Otolaryngol Head Neck Surg 2008 139 149-151
22. Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009 33 897-906
23. Harding SM. The potential role of gastroesophageal reflux in asthma. Minerva Gastroenterol Dietol 2001 47 75-83
24. Bisaccioni C, Aun MV, Cajuela E, Kalil J, Agondi RC, Giavina-Bianchi P. Comorbidities in severe asthma: frequency of rhinitis, nasal polyposis, gastroesophageal reflux disease, vocal cord dysfunction and bronchiectasis. Clinics 2009 64 769-773
25. Gibson PG, Vertigan AE. Speech pathology for chronic cough: a new approach. Pulm Pharmacol Ther 2009 22 159-162
26. Eryuksel E, Dogan M, Golabi P, Sehitoglu MA, Celikel T. Treatment of laryngopharyngeal reflux improves asthma symptoms in asthmatics. J Asthma 2006 43 539-542
27. American Lung Association Asthma Clinical Research Centers. Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009 360 1487-1499
28. Virchow JC. Asthma, Allergische Rhinitis, Sinusitis. Konzept der vereinten Atmewege HNO 2005 online
29. Hosemann W, Michelson A, Weindler J, Mang H, Wigand ME. Der Effekt der endonasalen Pansinus-Chirurgie. Einfluss der endonasalen Nasennebenhö hlenchirurgie auf die Lungenfunktion des Patienten mit Asthma bronchiale. Laryngo-Rhino-Otol 1990 69 521-526
30. Petri E. Therapieerfolge mit Budesonid beim Corticoidbedürftigen Intrinsic Asthma. Schweiz Med Wschr 1985 115 49
31. Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Cromptom GK. Frequency of voice problems and cough in patients using pressurized aerosol inhaler steroid preparations. Eur Respir J 1995 8 590-592
32. Bhalla RK, Taylor W, Jones AS, Roland NJ. The inflammation produced by corticosteroid inhalers in the pharynx in asthmatics. Clin Otolaryngol 2008 33 581-586
33. Babu S, Samuel P. The effects of inhaled steroids on the upper respiratory tract. J Laryngol Otol 1988 102 592-594
34. Lavy JA, Wood G, Rubin JS, Harries M. Dysphonia associated with inhaled steroids. J Voice 2000 14 581-588
35. Krecicki T, Liebhart J, Morawska-Kochman M, Liebhart E, Zatonski M, Zalesska-Krecicki M. Corticosteroid-induced larygeal disorders in asthma. Med Sci Monit 2006 12 351-354
36. Peters SP, Prenner BM, Mezzanotte WS, Martin P, OBrien CD. Long-term safety and asthma control with budesonid/formoterol budesonide pressurized metered-dose inhaler in asthma patients. Allergy Asthma Proc 2008 29 499-516
37. Toogood JH, Jennings B, Baskerville J, Anderson J, Johannson SA. Dosing regimen of budesonid and occurrence of oropharygeal complications. Eur J Respir Dis 1984 65 33-44
38. Corcoran TE, Chigier N. Characterization of the laryngeal jet using phase Doppler interferometry. J Aerosol Med 2000 13 125-137
39. Lipworth BJ, Clark DJ. Comparative lung delivery of salbutamol given Turbohaler and Diskus dry powder inhaler devices. Eur J Clin Pharmacol 1997 53 47-49
40. OCallaghan C, Barry P. Spacer devices in the treatment of asthma. BJM 1997 314 1061-1062